Hemab Therapeutics Holdings, Inc. Common Stock
(COAG - NASDAQ)
44,41 USD
📋 Profilo Aziendale

Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders.

|